XML 35 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Ordinary Share (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Class A Redeemable Ordinary Shares        
Numerator:        
Basic allocation of net loss including accretion of temporary equity $ (23,263,657)   $ (21,581,996)  
Diluted allocation of net loss including accretion of temporary equity $ (23,263,657)   $ (21,182,030)  
Denominator:        
Basic weighted average shares outstanding 35,880,000   19,582,857  
Diluted weighted average shares outstanding 35,880,000   19,582,857  
Basic net loss per common share $ (0.65)   $ (1.1)  
Diluted net loss per common share $ (0.65)   $ (1.08)  
Class A Non-Redeemable Ordinary Shares        
Numerator:        
Basic allocation of net loss including accretion of temporary equity $ (145,884)   $ (135,339)  
Diluted allocation of net loss including accretion of temporary equity $ (145,884)   $ (132,830)  
Denominator:        
Basic weighted average shares outstanding 225,000   122,802  
Diluted weighted average shares outstanding 225,000   122,802  
Basic net loss per common share $ (0.65)   $ (1.1)  
Diluted net loss per common share $ (0.65)   $ (1.08)  
Class B Ordinary Shares        
Numerator:        
Basic allocation of net loss including accretion of temporary equity $ (5,815,914) [1],[2]   $ (9,300,033)  
Diluted allocation of net loss including accretion of temporary equity $ (5,815,914) [1],[2]   $ (9,702,507)  
Denominator:        
Basic weighted average shares outstanding [3],[4] 8,970,000 7,800,000 8,438,571 7,800,000
Diluted weighted average shares outstanding [3],[4] 8,970,000 7,800,000 8,970,000 7,800,000
Basic net loss per common share $ (0.65) [1],[2]   $ (1.1)  
Diluted net loss per common share $ (0.65) [1],[2]   $ (1.08)  
[1] On June 30, 2023, the Sponsor paid $25,000 to cover certain of the Company’s offering costs in consideration of 11,500,000 Founder Shares. On February 3, 2025, the Sponsor surrendered for no consideration 4,025,000 Founder Shares. On May 1, 2025, the Company effected a stock dividend with respect to its Class B ordinary shares of 1,495,000 shares thereof, resulting in an aggregate of 8,970,000 outstanding shares of Class B ordinary shares.
[2] Until the completion of the IPO on May 5, 2025, an aggregate of up to 1,170,000 Class B ordinary shares, $0.0001 par value, were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On May 5, 2025, the Company consummated its Initial Public Offering and sold 35.88 million Units, which includes the full exercise of the underwriter's over-allotment option, hence the 1,170,000 Class B ordinary shares are no longer subject to forfeiture and excluded from diluted shares outstanding.
[3] On June 30, 2023, the Sponsor paid $25,000 to cover certain of the Company’s offering costs in consideration of 11,500,000 Founder Shares. On February 3, 2025, the Sponsor surrendered for no consideration 4,025,000 Founder Shares. On May 1, 2025, the Company effected a stock dividend with respect to its Class B ordinary shares of 1,495,000 shares thereof, resulting in an aggregate of 8,970,000 outstanding shares of Class B ordinary shares.
[4] Until the completion of the IPO on May 5, 2025, an aggregate of up to 1,170,000 Class B ordinary shares, $0.0001 par value, were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On May 5, 2025, the Company consummated its Initial Public Offering and sold 35.88 million Units, which includes the full exercise of the underwriter's over-allotment option, hence the 1,170,000 Class B ordinary shares are no longer subject to forfeiture and excluded from diluted shares outstanding.